KYMR earnings: a positive outcome, +7.5%

On November 3, 2022, Kymera Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.5% in the window around the event. It had already run +34.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.